Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Eugenio A. Cefali"'
Autor:
Jean-claude Tardif, Sameh Fikry, Ginette Girard, Tania Discenza, Annik Fortier, Eugenio A Cefali, Marie-Claude Guertin
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Background: 1-methylnicotinamide, a nicotinic acid metabolite, is TRIA-662’s active component. As part of a pilot study, we assessed TRIA-662’s effects on inflammatory biomarkers and blood lipids. Methods: Patients aged 18-80 years with mean seru
Publikováno v:
Biopharmaceutics & Drug Disposition. 30:508-516
Acipimox is an analog of nicotinic acid and is indicated for the treatment of dyslipidemia. It is also believed to improve glucose control by enhancing insulin sensitivity. The purpose of this study was to direct modified release (MR) formulation str
Publikováno v:
Biopharmaceutics & Drug Disposition. 28:297-306
Lovastatin and extended-release (ER) niacin in a fixed dose combination (Advicor®) is approved for the treatment of dyslipidemia. Since both drugs are extensively metabolized, this study investigated the bioavailability and pharmacokinetics of their
Publikováno v:
International Journal of Pharmaceutics. 127:147-154
A study in beagle dogs was carried out to estimate the bioavailability of silicon and aluminum from Zeolite A administered as a capsule, oral suspension, and oral solution relative to an intravenous bolus infusion (i.v.) administered over a 1-1.5 min
Publikováno v:
Pharmaceutical Research. 12:270-274
Zeolite A is a synthetic zeolite which may have therapeutic utility in osteoporotic individuals because of its ability to stimulate bone formation. A study of Zeolite A (30 mg/kg), sodium aluminosilicate (16 mg/kg), magnesium trisilicate (20 mg/kg),
Autor:
J H Leu, Rajeev M. Menon, Marijke H. Adams, Eugenio A. Cefali, Dwain Tolbert, Mario A. Gonzalez
Publikováno v:
International journal of clinical pharmacology and therapeutics. 45(8)
Objective To characterize plasma and urine pharmacokinetics of niacin and its metabolites after oral administration of 2,000 mg of extended-release (ER) niacin in healthy male volunteers. Methods Niacin ER was administered to 12 healthy male subjects
Autor:
Marijke H. Adams, Eugenio A. Cefali, Dwain Tolbert, Rajeev M. Menon, Mario A. Gonzalez, Jocelyn H. Leu
Publikováno v:
Journal of clinical pharmacology. 47(6)
The metabolic profile of niacin is influenced by the rate of niacin administration. This study characterizes the effect of administration rate on the pharmacokinetics of niacin and its metabolites. Twelve healthy males were enrolled in an open-label,
Publikováno v:
Journal of Pharmaceutical Sciences. 83:758-760
A pharmacokinetic study of the dopamine D2 receptor agonist (S)-(-)-2-(N-propyl-N-(2-thienylethyl)amino)-5-hydroxytetralin+ ++-HCl (N-0923) infused in female cynomolgus monkeys over a 4-h period was carried out at International Research and Developme
Autor:
Domenic A. Sica, Itaf Fakhry, Geoffrey Allan, Denise Lowe Walters, Eugenio A. Cefali, Don Farthing
Publikováno v:
Biomedical chromatography : BMC. 8(5)
Publikováno v:
Journal of pharmaceutical sciences. 80(10)